title: Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study.
authors.affiliation: Gynecology Department, Federal University of São Paulo, São Paulo, SP, Brazil.
authors.forename: José Gomes
authors.initials: JG
authors.lastname: Batista
authors.forename: José Maria
authors.initials: JM
authors.lastname: Soares
authors.forename: Carla Cristina
authors.initials: CC
authors.lastname: Maganhin
authors.forename: Ricardo Santos
authors.initials: RS
authors.lastname: Simões
authors.forename: Geraldez
authors.initials: G
authors.lastname: Tomaz
authors.forename: Edmund Chada
authors.initials: EC
authors.lastname: Baracat
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007333:Insulin Resistance / Q000502:physiology*; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000378:metabolism*; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D010865:Pilot Projects; D011085:Polycystic Ovary Syndrome / Q000188:drug therapy* / Q000378:metabolism; D000077154:Rosiglitazone; D018709:Statistics, Nonparametric; D045162:Thiazolidinediones / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D018972:Insulin-Like Growth Factor Binding Protein 3; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D007334:Insulin-Like Growth Factor I